Go Pro

Synaptics (SYNA) Financials

Synaptics logo
$109.76 +2.84 (+2.66%)
As of 11:18 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Synaptics

Annual Income Statements for Synaptics

This table shows Synaptics' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/25/2016 6/24/2017 6/30/2018 6/29/2019 6/27/2020 6/26/2021 6/25/2022 6/24/2023 6/29/2024 6/28/2025 6/27/2026
Net Income / (Loss) Attributable to Common Shareholders
72 49 -124 -23 119 80 258 74 126 -48 -491
Consolidated Net Income / (Loss)
72 49 -124 -23 119 80 258 74 126 -48 -491
Net Income / (Loss) Continuing Operations
72 49 -124 -23 119 80 258 74 126 -48 -491
Total Pre-Tax Income
76 61 -82 -21 159 120 321 126 -125 -114 -79
Total Operating Income
75 65 -62 -6.30 69 147 350 154 -102 -94 -67
Total Gross Profit
582 524 480 497 543 611 943 716 440 480 535
Total Revenue
1,667 1,718 1,630 1,472 1,334 1,340 1,740 1,355 959 1,074 1,197
Operating Revenue
1,667 1,718 1,630 1,472 1,334 1,340 1,740 1,355 959 1,074 1,197
Total Cost of Revenue
1,085 1,195 1,150 975 791 728 797 639 520 594 662
Operating Cost of Revenue
1,085 1,195 1,150 975 791 728 797 639 520 594 662
Total Operating Expenses
506 459 542 503 474 464 593 562 541 575 603
Selling, General & Admin Expense
162 138 154 131 127 145 168 175 161 180 198
Research & Development Expense
311 292 363 343 303 313 367 351 336 347 382
Amortization Expense
19 12 13 12 12 33 39 35 17 17 12
Impairment Charge
6.70 - - - - - - 0.00 16 14 6.80
Restructuring Charge
8.60 7.30 12 18 33 7.40 18 0.00 11 17 3.30
Total Other Income / (Expense), net
0.40 -3.40 -20 -15 91 -27 -30 -28 -23 -19 -12
Interest Expense
4.80 6.00 22 21 23 30 38 56 65 46 23
Interest & Investment Income
2.10 1.90 2.30 6.70 7.90 2.90 3.00 27 42 27 11
Income Tax Expense
3.40 12 41 0.30 39 31 65 52 -250 -66 411
Basic Earnings per Share
$1.97 $1.40 ($3.63) ($0.66) $3.54 $2.29 $6.60 $1.86 $3.20 ($1.22) ($12.62)
Weighted Average Basic Shares Outstanding
36.60M 34.80M 34.20M 34.60M 33.60M 34.80M 39M 39.60M 39.20M 39.30M 38.90M
Diluted Earnings per Share
$1.91 $1.37 ($3.63) ($0.66) $3.41 $2.08 $6.33 $1.83 $3.16 ($1.22) ($12.62)
Weighted Average Diluted Shares Outstanding
37.90M 35.60M 34.20M 34.60M 34.80M 38.30M 40.70M 40.20M 39.70M 39.30M 38.90M
Weighted Average Basic & Diluted Shares Outstanding
36.60M 34.90M 34.20M 32.91M 34.23M 38.85M 39.63M 38.58M 39.58M 38.66M 39.11M

Quarterly Income Statements for Synaptics

This table shows Synaptics' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026 6/27/2026
Net Income / (Loss) Attributable to Common Shareholders
-9.00 -18 208 -23 1.80 -22 -4.70 -21 -15 -8.00 -447
Consolidated Net Income / (Loss)
-9.00 -18 208 -23 1.80 -22 -4.70 -21 -15 -8.00 -447
Net Income / (Loss) Continuing Operations
-9.00 -18 208 -23 1.80 -22 -4.70 -21 -15 -8.00 -447
Total Pre-Tax Income
-24 -23 -37 -34 -26 -27 -26 -23 -18 -15 -24
Total Operating Income
-18 -17 -31 -28 -15 -26 -24 -23 -15 -13 -16
Total Gross Profit
109 110 113 121 122 116 122 125 132 133 146
Total Revenue
237 237 247 258 267 267 283 293 303 294 308
Operating Revenue
237 237 247 258 267 267 283 293 303 294 308
Total Cost of Revenue
128 127 134 137 145 151 161 168 171 161 162
Operating Cost of Revenue
128 127 134 137 145 151 161 168 171 161 162
Total Operating Expenses
127 128 145 149 137 142 146 148 147 146 162
Selling, General & Admin Expense
40 41 39 50 50 35 46 46 48 50 55
Research & Development Expense
82 83 84 81 83 89 94 94 95 95 98
Amortization Expense
3.90 4.00 3.90 3.80 3.80 4.50 4.60 4.70 3.80 1.90 1.90
Restructuring Charge
1.30 -0.20 1.40 14 0.80 0.50 1.40 2.50 0.10 0.00 0.70
Total Other Income / (Expense), net
-6.10 -5.90 -5.60 -5.90 -11 -1.10 -1.60 0.50 -2.40 -2.50 -7.90
Interest & Investment Income
- - - -5.90 -4.30 -1.10 - 0.50 -2.40 -2.50 16
Income Tax Expense
-15 -5.20 -245 -11 -28 -5.60 -21 -2.10 -2.70 -7.20 423
Basic Earnings per Share
($0.23) ($0.46) $5.32 ($0.58) $0.05 ($0.56) ($0.13) ($0.53) ($0.38) ($0.21) ($11.50)
Weighted Average Basic Shares Outstanding
39.20M 39.30M 39.20M 39.80M 39.70M 39M 39.30M 38.80M 38.90M 38.80M 38.90M
Diluted Earnings per Share
($0.23) ($0.46) $5.28 ($0.58) $0.05 ($0.56) ($0.13) ($0.53) ($0.38) ($0.21) ($11.50)
Weighted Average Diluted Shares Outstanding
39.20M 39.30M 39.70M 39.80M 39.80M 39M 39.30M 38.80M 38.90M 38.80M 38.90M
Weighted Average Basic & Diluted Shares Outstanding
39.30M 39.50M 39.58M 40.06M 39.19M 38.55M 38.66M 38.99M 38.73M 38.64M 39.11M

Annual Cash Flow Statements for Synaptics

This table details how cash moves in and out of Synaptics' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/25/2016 6/24/2017 6/30/2018 6/29/2019 6/27/2020 6/26/2021 6/25/2022 6/24/2023 6/29/2024 6/28/2025 6/27/2026
Net Change in Cash & Equivalents
-48 16 -67 27 436 73 -12 101 -48 -485 51
Net Cash From Operating Activities
257 153 145 154 222 319 463 332 136 142 149
Net Cash From Continuing Operating Activities
257 153 145 154 222 319 463 332 136 142 149
Net Income / (Loss) Continuing Operations
72 49 -124 -23 119 80 258 74 126 -48 -491
Consolidated Net Income / (Loss)
72 49 -124 -23 119 80 258 74 126 -48 -491
Depreciation Expense
31 33 39 36 27 22 24 27 28 29 31
Amortization Expense
74 61 102 93 70 148 124 130 82 114 119
Non-Cash Adjustments To Reconcile Net Income
71 60 73 56 -49 48 106 149 160 151 175
Changes in Operating Assets and Liabilities, net
8.40 -49 55 -7.20 55 22 -49 -49 -259 -105 316
Net Cash From Investing Activities
-27 -42 -439 -21 120 -523 -483 -6.00 -158 -298 13
Net Cash From Continuing Investing Activities
-27 -42 -439 -21 120 -523 -483 -6.00 -158 -298 13
Purchase of Property, Plant & Equipment
-29 -31 -34 -24 -16 -21 -31 -34 -34 -26 -48
Acquisitions
-4.60 -18 -404 0.00 -2.50 -627 -501 -16 -14 -211 0.00
Purchase of Investments
0.00 -17 - 0.00 0.00 -5.00 -36 0.00 -137 -61 0.00
Sale and/or Maturity of Investments
6.60 7.50 0.00 2.80 0.00 96 24 44 27 0.00 61
Net Cash From Financing Activities
-281 -94 227 -107 94 274 14 -221 -25 -331 -112
Net Cash From Continuing Financing Activities
-281 -94 227 -107 94 274 14 -221 -25 -331 -112
Repayment of Debt
-7.90 -20 -221 0.00 -0.70 -106 -11 -0.90 -4.10 -587 -1.60
Repurchase of Common Equity
-241 -88 -94 -119 -30 0.00 0.00 -184 0.00 -128 -93
Issuance of Debt
0.00 0.00 515 0.00 100 400 600 0.00 0.00 440 0.00
Issuance of Common Equity
32 25 32 21 35 28 15 18 16 14 17
Other Financing Activities, net
-4.10 -5.50 -5.40 -9.40 -9.70 -48 -590 -55 -37 -70 -34
Effect of Exchange Rate Changes
3.40 -0.90 0.00 0.10 0.00 2.20 -6.60 -3.50 -0.90 1.90 0.10
Cash Interest Paid
5.00 6.00 3.80 3.60 3.70 9.60 25 52 63 39 21
Cash Income Taxes Paid
47 22 26 16 19 0.00 - 91 55 47 3.20

Quarterly Cash Flow Statements for Synaptics

This table details how cash moves in and out of Synaptics' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026 6/27/2026
Net Change in Cash & Equivalents
45 -18 49 -23 -258 -236 31 68 -23 -33 38
Net Cash From Operating Activities
39 -14 65 -11 23 73 57 30 30 22 68
Net Cash From Continuing Operating Activities
39 -14 65 -11 23 73 57 30 30 22 68
Net Income / (Loss) Continuing Operations
-9.00 -18 208 -23 1.80 -22 -4.70 -21 -15 -8.00 -447
Consolidated Net Income / (Loss)
-9.00 -18 208 -23 1.80 -22 -4.70 -21 -15 -8.00 -447
Depreciation Expense
6.80 6.80 6.80 7.20 7.40 7.20 7.10 7.50 7.60 7.90 7.80
Amortization Expense
18 18 22 25 25 31 34 35 34 26 24
Non-Cash Adjustments To Reconcile Net Income
34 34 46 31 44 38 39 39 42 43 51
Changes in Operating Assets and Liabilities, net
-11 -55 -218 -51 -55 19 -18 -31 -39 -47 433
Net Cash From Investing Activities
10 -6.90 -11 -9.10 -5.50 -274 -8.90 49 -12 -12 -12
Net Cash From Continuing Investing Activities
10 -6.90 -11 -9.10 -5.50 -274 -8.90 49 -12 -12 -12
Purchase of Property, Plant & Equipment
-10 -9.00 -7.70 -9.10 -4.70 -5.40 -6.60 -12 -12 -12 -12
Net Cash From Financing Activities
-5.80 3.50 -4.70 -3.50 -275 -35 -18 -10 -41 -43 -18
Net Cash From Continuing Financing Activities
-5.80 3.50 -4.70 -3.50 -275 -35 -18 -10 -41 -43 -18
Repayment of Debt
-1.50 0.20 -1.50 0.10 -587 -0.30 - 0.00 - - -1.60
Repurchase of Common Equity
- - - 0.00 - -38 -16 -7.20 -36 -39 -10
Issuance of Common Equity
- 7.40 - 7.70 - 6.20 - 7.40 - - 9.80
Other Financing Activities, net
-4.30 -4.10 -3.20 -11 -53 -2.90 -2.40 -11 -4.30 -3.80 -16
Effect of Exchange Rate Changes
1.10 -0.90 -0.50 0.70 -0.10 0.10 1.20 -0.20 - -0.10 0.40

Annual Balance Sheets for Synaptics

This table presents Synaptics' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/25/2016 6/24/2017 6/30/2018 6/29/2019 6/27/2020 6/26/2021 6/25/2022 6/24/2023 6/29/2024 6/28/2025 6/27/2026
Total Assets
1,300 1,267 1,500 1,410 1,694 2,227 2,858 2,611 2,825 2,584 2,102
Total Current Assets
780 792 740 731 1,078 1,180 1,403 1,272 1,162 752 787
Cash & Equivalents
352 368 301 328 763 836 824 925 877 392 443
Short-Term Investments
- - - - - 0.00 52 9.60 0.00 61 0.00
Accounts Receivable
253 255 289 230 195 228 322 164 142 130 164
Inventories, net
146 131 131 159 102 82 170 137 114 140 156
Prepaid Expenses
29 38 18 15 17 33 36 37 29 30 24
Plant, Property, & Equipment, net
113 114 118 103 84 91 63 66 76 72 87
Total Noncurrent Assets
407 361 643 576 532 956 1,392 1,273 1,587 1,760 1,228
Goodwill
207 207 373 373 361 570 807 816 816 872 872
Intangible Assets
160 101 219 145 93 302 390 299 288 262 188
Noncurrent Deferred & Refundable Income Taxes
- - - - - - - 68 346 409 6.20
Other Noncurrent Operating Assets
40 53 51 58 78 84 195 90 137 217 162
Total Liabilities & Shareholders' Equity
1,300 1,267 1,500 1,410 1,694 2,227 2,858 0.00 2,825 2,584 2,102
Total Liabilities
595 527 771 753 875 1,260 1,592 1,368 1,358 1,190 1,173
Total Current Liabilities
351 310 284 254 244 787 463 260 277 271 701
Short-Term Debt
19 15 - - 0.00 0.00 6.00 6.00 6.00 0.00 440
Accounts Payable
173 136 157 98 61 98 142 46 88 99 83
Accrued Expenses
82 102 80 106 91 96 145 99 184 172 179
Total Noncurrent Liabilities
244 216 487 499 631 473 1,128 1,108 1,081 919 471
Long-Term Debt
217 202 451 468 587 394 976 972 967 835 398
Other Noncurrent Operating Liabilities
19 14 36 30 44 79 153 136 114 84 74
Total Equity & Noncontrolling Interests
705 740 729 657 819 967 1,266 1,243 1,467 1,395 930
Total Preferred & Common Equity
705 740 729 657 819 967 1,266 1,243 1,467 1,395 930
Preferred Stock
0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00
Total Common Equity
705 740 729 657 819 967 1,266 1,243 1,467 1,395 930
Common Stock
929 1,005 1,195 1,266 1,340 1,392 924 1,009 1,107 1,212 1,330
Retained Earnings
665 714 606 584 701 781 1,039 1,112 1,238 1,190 699
Treasury Stock
-892 -980 -1,074 -1,192 -1,223 -1,205 -695 -878 -878 -1,007 -1,100

Quarterly Balance Sheets for Synaptics

This table presents Synaptics' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/24/2022 3/25/2023 9/30/2023 12/30/2023 3/30/2024 9/28/2024 12/28/2024 3/29/2025 9/27/2025 12/27/2025 3/28/2026
Total Assets
2,725 2,715 2,549 2,573 2,540 2,791 2,528 2,554 2,577 2,563 2,522
Total Current Assets
1,324 1,334 1,109 1,147 1,123 1,140 891 713 749 771 755
Cash & Equivalents
819 898 801 846 828 854 596 360 460 437 404
Short-Term Investments
40 36 23 2.60 0.50 - - 61 0.00 0.00 0.00
Accounts Receivable
255 218 111 127 145 136 147 132 120 133 163
Inventories, net
178 148 132 125 114 120 120 133 143 158 161
Prepaid Expenses
33 34 41 47 35 31 28 26 27 43 27
Plant, Property, & Equipment, net
66 69 67 71 74 80 75 71 77 83 83
Total Noncurrent Assets
1,335 1,311 1,373 1,355 1,343 1,572 1,562 1,771 1,751 1,709 1,685
Goodwill
816 816 816 816 816 816 820 872 872 872 872
Intangible Assets
334 331 289 270 252 264 242 296 270 236 210
Noncurrent Deferred & Refundable Income Taxes
- - - - - 358 369 389 413 418 424
Other Noncurrent Operating Assets
185 164 268 268 275 133 131 213 196 183 179
Total Liabilities & Shareholders' Equity
2,725 2,715 2,549 2,573 2,540 2,791 2,528 2,554 2,577 2,563 2,522
Total Liabilities
1,425 1,394 1,344 1,353 1,304 1,324 1,151 1,167 1,177 1,180 1,164
Total Current Liabilities
299 269 246 253 211 254 230 248 262 263 248
Accounts Payable
83 61 64 83 71 83 84 90 93 96 78
Accrued Expenses
113 94 103 104 99 136 115 111 170 168 171
Total Noncurrent Liabilities
1,126 1,125 1,099 1,100 1,093 1,070 922 920 915 916 916
Long-Term Debt
974 973 970 969 968 966 833 834 835 836 837
Other Noncurrent Operating Liabilities
152 152 129 131 126 104 89 86 79 80 79
Total Equity & Noncontrolling Interests
1,300 1,321 1,204 1,220 1,235 1,467 1,376 1,387 1,401 1,384 1,359
Total Preferred & Common Equity
1,300 1,321 1,204 1,220 1,235 1,467 1,376 1,387 1,401 1,384 1,359
Preferred Stock
- - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,300 1,321 1,204 1,220 1,235 1,467 1,376 1,387 1,401 1,384 1,359
Common Stock
946 981 1,026 1,051 1,084 1,131 1,112 1,183 1,245 1,280 1,302
Retained Earnings
1,125 1,136 1,057 1,048 1,029 1,215 1,216 1,195 1,169 1,155 1,147
Treasury Stock
-769 -795 -878 -878 -878 -878 -953 -991 -1,014 -1,051 -1,090

Annual Metrics And Ratios for Synaptics

This table displays calculated financial ratios and metrics derived from Synaptics' official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/25/2016 6/24/2017 6/30/2018 6/29/2019 6/27/2020 6/26/2021 6/25/2022 6/24/2023 6/29/2024 6/28/2025 6/27/2026
DEI Shares Outstanding
- - - - - - - - - - 38,637,685.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 38,637,685.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - -12.70
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-2.12% 3.08% -5.12% -9.70% -9.39% 0.43% 29.87% -22.11% -29.20% 11.98% 11.44%
EBITDA Growth
-33.37% -13.30% -50.09% 53.40% 122.50% 16.72% 59.12% -37.99% -97.56% 544.74% 68.78%
EBIT Growth
-51.73% -16.48% -194.65% 89.82% 2,861.90% -15.52% 142.04% -56.63% -165.85% 7.38% 28.69%
NOPAT Growth
-35.75% -27.84% -183.61% 89.82% 1,284.02% 107.92% 157.70% -67.78% -178.91% 7.38% 28.69%
Net Income Growth
-34.60% -32.41% -354.30% 81.55% 618.78% -33.00% 223.49% -71.42% 70.65% -138.06% -926.78%
EPS Growth
-32.75% -28.27% -364.96% 81.82% 616.67% -39.00% 204.33% -71.09% 72.68% -138.61% -934.43%
Operating Cash Flow Growth
25.72% -40.41% -5.17% 6.34% 43.84% 43.91% 44.96% -28.36% -59.00% 4.49% 5.21%
Free Cash Flow Firm Growth
144.15% -57.42% -756.36% 123.06% 170.50% 8.59% -351.38% 130.89% -298.03% 19.19% 244.84%
Invested Capital Growth
-7.44% 0.19% 49.13% -9.24% -19.49% -18.22% 161.20% -6.19% 21.42% 13.72% -25.48%
Revenue Q/Q Growth
-8.51% 6.35% -2.28% -5.97% -1.30% 3.89% 9.34% -15.53% 2.14% 3.41% 2.15%
EBITDA Q/Q Growth
-26.78% 32.25% 0.00% -22.32% 104.99% -8.77% 10.01% -30.69% -38.71% 66.10% -1.66%
EBIT Q/Q Growth
-45.70% 174.79% -28.69% -127.16% 601.61% -28.22% 26.17% -50.66% 6.36% 6.83% 10.77%
NOPAT Q/Q Growth
-35.83% 110.84% -75.85% -103.38% 249.24% 25.03% 24.83% -54.79% 6.36% 6.83% 10.77%
Net Income Q/Q Growth
-34.72% 104.18% -18.42% -205.05% 782.76% -47.49% 33.70% -59.09% 218.38% -128.93% -920.37%
EPS Q/Q Growth
-33.68% 98.55% -16.72% -203.13% 810.42% -50.48% 33.54% -58.78% 217.47% -129.12% -909.60%
Operating Cash Flow Q/Q Growth
46.63% -29.77% -21.83% 29.91% 4.77% 19.19% 11.95% -15.28% -17.84% -5.21% 7.48%
Free Cash Flow Firm Q/Q Growth
27.14% -19.84% -13.85% -37.37% 64.18% 180.66% -532.96% -19.91% -283.86% 42.80% 1,025.94%
Invested Capital Q/Q Growth
-6.60% -0.30% 2.33% -7.95% -8.92% -50.98% -0.96% -5.78% 13.21% -1.26% -26.06%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
34.89% 30.47% 29.45% 33.77% 40.72% 45.63% 54.21% 52.83% 45.84% 44.72% 44.72%
EBITDA Margin
11.01% 9.26% 4.87% 8.27% 20.32% 23.61% 28.93% 23.03% 0.79% 4.56% 6.91%
Operating Margin
4.51% 3.77% -3.80% -0.43% 5.17% 10.97% 20.14% 11.39% -10.59% -8.76% -5.60%
EBIT Margin
4.70% 3.81% -3.80% -0.43% 13.04% 10.97% 20.45% 11.39% -10.59% -8.76% -5.60%
Profit (Net Income) Margin
4.33% 2.84% -7.61% -1.56% 8.91% 5.94% 14.80% 5.43% 13.09% -4.45% -41.00%
Tax Burden Percent
95.50% 79.61% 151.71% 110.10% 74.53% 66.28% 80.34% 58.41% -100.80% 42.11% 618.14%
Interest Burden Percent
96.55% 93.73% 132.15% 330.16% 91.61% 81.70% 90.08% 81.66% 122.64% 120.62% 118.33%
Effective Tax Rate
4.50% 19.90% 0.00% 0.00% 24.22% 26.14% 20.16% 41.59% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
11.74% 8.80% -5.90% -0.53% 7.25% 18.60% 29.49% 6.78% -4.99% -3.94% -3.03%
ROIC Less NNEP Spread (ROIC-NNEP)
11.46% 11.06% 14,679.55% -13.27% -359.61% 27.96% 42.74% -15.35% 276.64% 3.61% -117.26%
Return on Net Nonoperating Assets (RNNOA)
-2.10% -2.05% -10.99% -2.78% 8.84% -9.68% -6.43% -0.91% 14.26% 0.60% -39.20%
Return on Equity (ROE)
9.64% 6.75% -16.89% -3.30% 16.09% 8.91% 23.06% 5.87% 9.27% -3.34% -42.23%
Cash Return on Invested Capital (CROIC)
19.47% 8.61% -45.35% 9.16% 28.85% 38.64% -59.77% 13.17% -24.34% -16.78% 26.18%
Operating Return on Assets (OROA)
5.55% 5.10% -4.48% -0.43% 11.21% 7.50% 13.99% 5.64% -3.74% -3.48% -2.86%
Return on Assets (ROA)
5.12% 3.80% -8.97% -1.57% 7.66% 4.06% 10.13% 2.69% 4.62% -1.77% -20.95%
Return on Common Equity (ROCE)
9.64% 6.75% -16.89% -3.30% 16.09% 8.91% 23.06% 5.87% 9.27% -3.34% -42.23%
Return on Equity Simple (ROE_SIMPLE)
10.24% 6.59% -17.02% -3.48% 14.50% 8.23% 20.33% 5.92% 8.56% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
72 52 -43 -4.41 52 109 280 90 -71 -66 -47
NOPAT Margin
4.31% 3.02% -2.66% -0.30% 3.91% 8.10% 16.08% 6.65% -7.41% -6.13% -3.92%
Net Nonoperating Expense Percent (NNEP)
0.28% -2.26% -14,685.45% 12.74% 366.86% -9.36% -13.25% 22.13% -281.63% -7.56% 114.23%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - -2.95% -2.66%
Cost of Revenue to Revenue
65.11% 69.53% 70.55% 66.23% 59.28% 54.37% 45.79% 47.17% 54.16% 55.28% 55.28%
SG&A Expenses to Revenue
9.70% 8.01% 9.45% 8.92% 9.52% 10.82% 9.68% 12.91% 16.81% 16.78% 16.56%
R&D to Revenue
18.67% 17.01% 22.28% 23.28% 22.68% 23.40% 21.11% 25.92% 35.05% 32.28% 31.89%
Operating Expenses to Revenue
30.37% 26.71% 33.25% 34.19% 35.55% 34.65% 34.07% 41.44% 56.43% 53.48% 50.33%
Earnings before Interest and Taxes (EBIT)
78 65 -62 -6.30 174 147 356 154 -102 -94 -67
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
184 159 79 122 271 316 503 312 7.60 49 83
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.73 2.78 2.39 1.53 2.34 5.37 4.03 2.58 2.38 1.79 5.03
Price to Tangible Book Value (P/TBV)
5.69 4.76 12.70 7.20 5.25 54.29 73.07 24.96 9.62 9.59 0.00
Price to Revenue (P/Rev)
1.15 1.20 1.07 0.68 1.44 3.88 2.93 2.37 3.63 2.32 3.91
Price to Earnings (P/E)
26.65 42.17 0.00 0.00 16.12 65.27 19.81 43.58 27.74 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
3.75% 2.37% 0.00% 0.00% 6.20% 1.53% 5.05% 2.29% 3.61% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
3.07 3.24 2.15 1.44 2.71 9.05 3.79 2.53 2.29 1.62 3.83
Enterprise Value to Revenue (EV/Rev)
1.08 1.11 1.16 0.78 1.30 3.55 2.99 2.40 3.73 2.68 4.23
Enterprise Value to EBITDA (EV/EBITDA)
9.85 11.99 23.84 9.41 6.41 15.03 10.34 10.42 471.01 58.76 61.31
Enterprise Value to EBIT (EV/EBIT)
23.08 29.16 0.00 0.00 9.99 32.33 14.63 21.07 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
25.16 36.80 0.00 0.00 33.29 43.78 18.61 36.07 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
7.04 12.47 13.06 7.43 7.84 14.89 11.25 9.81 26.34 20.28 33.94
Enterprise Value to Free Cash Flow (EV/FCFF)
15.17 37.60 0.00 14.92 8.37 21.07 0.00 18.57 0.00 0.00 12.49
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.33 0.29 0.62 0.71 0.72 0.41 0.78 0.79 0.66 0.60 0.90
Long-Term Debt to Equity
0.31 0.27 0.62 0.71 0.72 0.41 0.77 0.78 0.66 0.60 0.43
Financial Leverage
-0.18 -0.19 0.00 0.21 -0.02 -0.35 -0.15 0.06 0.05 0.17 0.33
Leverage Ratio
1.88 1.78 1.88 2.10 2.10 2.19 2.28 2.18 2.01 1.89 2.02
Compound Leverage Factor
1.82 1.66 2.49 6.93 1.93 1.79 2.05 1.78 2.46 2.28 2.39
Debt to Total Capital
25.04% 22.67% 38.19% 41.60% 41.73% 28.97% 43.67% 44.03% 39.88% 37.44% 47.39%
Short-Term Debt to Total Capital
2.00% 1.57% 0.00% 0.00% 0.00% 0.00% 0.27% 0.27% 0.25% 0.00% 24.88%
Long-Term Debt to Total Capital
23.04% 21.10% 38.19% 41.60% 41.73% 28.97% 43.40% 43.76% 39.63% 37.44% 22.51%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
74.96% 77.33% 61.81% 58.40% 58.27% 71.03% 56.33% 55.97% 60.12% 62.56% 52.61%
Debt to EBITDA
1.28 1.36 5.68 3.84 2.16 1.25 1.95 3.13 128.01 17.04 10.12
Net Debt to EBITDA
-0.64 -0.95 1.89 1.15 -0.65 -1.40 0.21 0.14 12.63 7.80 4.77
Long-Term Debt to EBITDA
1.18 1.27 5.68 3.84 2.16 1.25 1.94 3.11 127.22 17.04 4.81
Debt to NOPAT
3.28 4.19 -10.40 -106.19 11.23 3.63 3.51 10.85 -13.68 -12.67 -17.83
Net Debt to NOPAT
-1.62 -2.91 -3.45 -31.86 -3.39 -4.07 0.38 0.48 -1.35 -5.80 -8.41
Long-Term Debt to NOPAT
3.02 3.90 -10.40 -106.19 11.23 3.63 3.49 10.78 -13.60 -12.67 -8.47
Altman Z-Score
4.53 5.12 3.24 2.82 3.61 4.00 3.85 3.18 2.75 2.42 3.37
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.22 2.55 2.61 2.88 4.41 1.50 3.03 4.89 4.19 2.78 1.12
Quick Ratio
1.72 2.01 2.08 2.20 3.93 1.35 2.59 4.22 3.68 2.15 0.86
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
119 51 -333 77 208 226 -567 175 -347 -280 406
Operating Cash Flow to CapEx
897.20% 486.94% 425.22% 650.63% 0.00% 1,512.80% 0.00% 972.14% 402.07% 550.39% 311.25%
Free Cash Flow to Firm to Interest Expense
24.82 8.45 -15.00 3.62 9.23 7.57 -14.80 3.16 -5.31 -6.05 17.35
Operating Cash Flow to Interest Expense
53.46 25.48 6.53 7.27 9.86 10.71 12.08 5.97 2.08 3.07 6.38
Operating Cash Flow Less CapEx to Interest Expense
47.50 20.25 5.00 6.16 15.30 10.00 12.73 5.36 1.56 2.51 4.33
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.18 1.34 1.18 1.01 0.86 0.68 0.68 0.50 0.35 0.40 0.51
Accounts Receivable Turnover
5.78 6.77 5.99 5.67 6.27 6.32 6.32 5.58 6.26 7.88 8.14
Inventory Turnover
7.57 8.60 8.76 6.73 6.07 7.92 6.33 4.17 4.14 4.69 4.47
Fixed Asset Turnover
14.12 15.17 14.08 13.34 14.24 15.27 22.58 20.96 13.52 14.56 15.06
Accounts Payable Turnover
6.01 7.74 7.86 7.64 9.95 9.21 6.66 6.81 7.80 6.39 7.31
Days Sales Outstanding (DSO)
63.19 53.94 60.93 64.35 58.19 57.71 57.74 65.45 58.27 46.33 44.86
Days Inventory Outstanding (DIO)
48.19 42.44 41.67 54.26 60.16 46.10 57.66 87.62 88.23 77.90 81.60
Days Payable Outstanding (DPO)
60.75 47.15 46.44 47.76 36.67 39.64 54.85 53.56 46.82 57.16 49.94
Cash Conversion Cycle (CCC)
50.63 49.23 56.15 70.84 81.68 64.17 60.56 99.51 99.68 67.07 76.52
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
588 589 879 798 642 525 1,372 1,287 1,563 1,777 1,324
Invested Capital Turnover
2.72 2.92 2.22 1.76 1.85 2.29 1.83 1.02 0.67 0.64 0.77
Increase / (Decrease) in Invested Capital
-47 1.10 290 -81 -156 -117 847 -85 276 214 -453
Enterprise Value (EV)
1,807 1,907 1,893 1,146 1,738 4,753 5,206 3,251 3,580 2,879 5,070
Market Capitalization
1,924 2,058 1,744 1,005 1,915 5,195 5,101 3,208 3,484 2,497 4,675
Book Value per Share
$19.14 $21.58 $21.07 $19.05 $24.07 $27.48 $31.97 $31.46 $37.14 $36.19 $24.06
Tangible Book Value per Share
$9.17 $12.60 $3.97 $4.05 $10.72 $2.72 $1.76 $3.25 $9.17 $6.76 ($3.38)
Total Capital
941 957 1,180 1,126 1,406 1,362 2,248 2,221 2,440 2,230 1,767
Total Debt
236 217 451 468 587 394 982 978 973 835 837
Total Long-Term Debt
217 202 451 468 587 394 976 972 967 835 398
Net Debt
-117 -151 150 141 -177 -442 106 44 96 382 395
Capital Expenditures (CapEx)
29 31 34 24 -122 21 -25 34 34 26 48
Debt-free, Cash-free Net Working Capital (DFCFNWC)
96 129 155 149 70 -443 70 84 14 29 83
Debt-free Net Working Capital (DFNWC)
448 497 456 477 834 393 946 1,018 891 481 525
Net Working Capital (NWC)
429 482 456 477 834 393 940 1,012 885 481 86
Net Nonoperating Expense (NNE)
-0.38 3.02 81 18 -67 29 22 17 -197 -18 444
Net Nonoperating Obligations (NNO)
-117 -151 150 141 -177 -442 106 44 96 382 395
Total Depreciation and Amortization (D&A)
105 94 141 128 97 169 148 158 109 143 150
Debt-free, Cash-free Net Working Capital to Revenue
5.75% 7.50% 9.49% 10.15% 5.26% -33.09% 4.02% 6.17% 1.48% 2.65% 6.92%
Debt-free Net Working Capital to Revenue
26.88% 28.90% 27.95% 32.41% 62.49% 29.34% 54.38% 75.12% 92.88% 44.77% 43.88%
Net Working Capital to Revenue
25.75% 28.03% 27.95% 32.41% 62.49% 29.34% 54.03% 74.67% 92.26% 44.77% 7.16%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.97 $1.40 ($3.63) ($0.66) $3.54 $2.29 $6.60 $1.86 $3.20 ($1.22) ($12.62)
Adjusted Weighted Average Basic Shares Outstanding
36.60M 34.80M 34.20M 34.60M 33.60M 34.80M 39M 39.60M 39.20M 39.30M 38.90M
Adjusted Diluted Earnings per Share
$1.91 $1.37 ($3.63) ($0.66) $3.41 $2.08 $6.33 $1.83 $3.16 ($1.22) ($12.62)
Adjusted Weighted Average Diluted Shares Outstanding
37.90M 35.60M 34.20M 34.60M 34.80M 38.30M 40.70M 40.20M 39.70M 39.30M 38.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
34.81M 33.70M 35.36M 32.91M 34.23M 38.85M 39.63M 38.58M 39.58M 38.66M 39.11M
Normalized Net Operating Profit after Tax (NOPAT)
86 66 -35 7.98 77 89 294 90 -53 -44 -40
Normalized NOPAT Margin
5.16% 3.82% -2.14% 0.54% 5.79% 6.63% 16.92% 6.65% -5.48% -4.13% -3.33%
Pre Tax Income Margin
4.54% 3.57% -5.02% -1.41% 11.95% 8.97% 18.42% 9.30% -12.99% -10.57% -6.63%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
16.31 10.90 -2.79 -0.30 7.73 4.93 9.29 2.78 -1.56 -2.03 -2.87
NOPAT to Interest Expense
14.96 8.64 -1.95 -0.21 2.32 3.64 7.30 1.62 -1.09 -1.42 -2.01
EBIT Less CapEx to Interest Expense
10.35 5.67 -4.32 -1.42 13.17 4.22 9.94 2.17 -2.07 -2.59 -4.92
NOPAT Less CapEx to Interest Expense
9.00 3.40 -3.49 -1.33 7.76 2.94 7.95 1.01 -1.61 -1.98 -4.06
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
84.35% 10.86% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
417.59% 191.19% -75.42% -517.47% 25.42% 0.00% 0.00% 249.32% 0.00% -268.41% -18.89%

Quarterly Metrics And Ratios for Synaptics

This table displays calculated financial ratios and metrics derived from Synaptics' official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026 6/27/2026
DEI Shares Outstanding
- - - - - - - - - 38,729,741.00 38,637,685.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 38,729,741.00 38,637,685.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - -0.21 -11.58
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-32.88% -27.34% 8.84% 8.41% 12.74% 12.35% 14.31% 13.50% 13.21% 10.35% 8.91%
EBITDA Growth
-90.77% -97.31% -218.18% 172.34% 133.33% 54.55% 750.00% 473.53% 57.74% 78.15% -8.28%
EBIT Growth
-145.43% -185.66% 18.16% 19.32% 15.08% -51.15% 22.19% 18.31% 0.66% 51.71% 33.47%
NOPAT Growth
-148.68% -193.14% 18.16% 19.32% 15.08% -51.15% 22.19% 18.31% 0.66% 51.71% 33.47%
Net Income Growth
-140.91% -274.04% 990.17% 58.45% 120.00% -20.44% -102.26% 10.82% -922.22% 63.30% -9,419.15%
EPS Growth
-141.82% -276.92% 1,026.32% 59.44% 121.74% -21.74% -102.46% 8.62% -860.00% 62.50% -8,746.15%
Operating Cash Flow Growth
-21.60% -112.63% -31.22% -125.11% -41.84% 635.77% -12.00% 364.91% 30.70% -70.30% 18.18%
Free Cash Flow Firm Growth
131.39% -182.10% -609.37% -1,890.69% -542.45% -1,546.76% 22.23% 17.30% 34.81% 99.98% 290.90%
Invested Capital Growth
-5.28% 1.05% 21.42% 16.98% 19.77% 30.37% 13.72% 12.01% 10.54% -0.49% -25.48%
Revenue Q/Q Growth
-0.29% 0.13% 4.26% 4.16% 3.69% -0.22% 6.08% 3.43% 3.42% -2.74% 4.69%
EBITDA Q/Q Growth
253.19% 63.64% -244.44% 230.77% 394.12% -29.17% 42.02% 15.38% 35.90% -20.00% -26.89%
EBIT Q/Q Growth
49.15% 2.92% -33.48% 8.68% 46.48% -73.03% 7.98% 4.13% 34.91% 15.89% -26.77%
NOPAT Q/Q Growth
49.15% 2.79% -78.74% 8.68% 46.48% -73.03% 7.98% 4.13% 34.91% 15.89% -26.77%
Net Income Q/Q Growth
83.81% -101.11% 1,250.83% -111.09% 107.79% -1,311.11% 78.44% -338.30% 28.16% 45.95% -5,492.50%
EPS Q/Q Growth
83.92% -100.00% 1,247.83% -110.98% 108.62% -1,220.00% 76.79% -307.69% 28.30% 44.74% -5,376.19%
Operating Cash Flow Q/Q Growth
-13.66% -134.95% 574.45% -117.54% 300.00% 221.93% -22.07% -47.20% -1.32% -26.85% 210.09%
Free Cash Flow Firm Q/Q Growth
348.21% -142.48% -1,019.15% 15.96% -10.74% -58.11% 47.15% 10.63% 12.71% 99.95% 490,800.00%
Invested Capital Q/Q Growth
-0.68% 2.54% 13.21% 1.46% 1.70% 11.62% -1.26% -0.06% 0.35% 0.48% -26.06%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
45.99% 46.48% 45.84% 46.92% 45.73% 43.44% 42.96% 42.60% 43.54% 45.31% 47.34%
EBITDA Margin
3.04% 0.76% -1.05% 1.32% 6.29% 4.46% 5.98% 6.67% 8.76% 7.21% 5.03%
Operating Margin
-7.55% -7.33% -12.57% -11.02% -5.69% -9.87% -8.56% -7.93% -4.99% -4.32% -5.23%
EBIT Margin
-7.55% -9.82% -12.57% -11.02% -5.69% -9.87% -8.56% -7.93% -4.99% -4.32% -5.23%
Profit (Net Income) Margin
-3.80% -7.63% 84.20% -8.96% 0.67% -8.18% -1.66% -7.04% -4.89% -2.72% -145.26%
Tax Burden Percent
37.50% 77.68% -567.57% 67.35% -6.92% 79.56% 18.22% 90.75% 84.57% 52.63% 1,864.17%
Interest Burden Percent
134.08% 100.00% 118.01% 120.77% 171.05% 104.18% 106.61% 97.84% 115.89% 119.69% 149.07%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-3.93% -3.51% -5.92% -5.14% -2.72% -4.51% -3.85% -3.66% -2.36% -1.97% -2.82%
ROIC Less NNEP Spread (ROIC-NNEP)
-1.07% -9.74% 323.45% -7.53% 4.15% -5.73% 1.26% -5.43% -3.69% -1.76% -115.07%
Return on Net Nonoperating Assets (RNNOA)
-0.11% -0.72% 16.67% -0.76% 0.58% -1.22% 0.21% -0.93% -0.85% -0.54% -38.47%
Return on Equity (ROE)
-4.03% -4.23% 10.75% -5.90% -2.14% -5.73% -3.64% -4.60% -3.20% -2.51% -41.30%
Cash Return on Invested Capital (CROIC)
2.55% -6.58% -24.34% -20.16% -22.35% -30.81% -16.78% -15.04% -13.67% -2.44% 26.18%
Operating Return on Assets (OROA)
-2.93% -3.51% -4.44% -4.04% -2.25% -4.02% -3.40% -3.28% -2.24% -1.99% -2.67%
Return on Assets (ROA)
-1.47% -2.73% 29.72% -3.29% 0.27% -3.34% -0.66% -2.91% -2.20% -1.26% -74.22%
Return on Common Equity (ROCE)
-4.03% -4.23% 10.75% -5.90% -2.14% -5.73% -3.64% -4.60% -3.20% -2.51% -41.30%
Return on Equity Simple (ROE_SIMPLE)
-6.36% -8.59% 0.00% 10.77% 12.27% 11.91% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-13 -12 -22 -20 -11 -18 -17 -16 -11 -8.89 -11
NOPAT Margin
-5.29% -5.13% -8.80% -7.71% -3.98% -6.91% -5.99% -5.55% -3.49% -3.02% -3.66%
Net Nonoperating Expense Percent (NNEP)
-2.86% 6.23% -329.38% 2.39% -6.87% 1.22% -5.12% 1.77% 1.33% -0.21% 112.25%
Return On Investment Capital (ROIC_SIMPLE)
-0.57% - - - -0.48% -0.83% -0.76% -0.73% -0.48% -0.40% -0.64%
Cost of Revenue to Revenue
54.01% 53.52% 54.16% 53.09% 54.27% 56.56% 57.04% 57.40% 56.46% 54.69% 52.66%
SG&A Expenses to Revenue
16.75% 17.07% 15.68% 19.40% 18.53% 13.02% 16.30% 15.79% 15.80% 16.86% 17.76%
R&D to Revenue
34.60% 35.15% 34.11% 31.55% 31.18% 33.23% 33.10% 32.27% 31.44% 32.12% 31.75%
Operating Expenses to Revenue
53.54% 53.81% 58.41% 57.94% 51.42% 53.30% 51.52% 50.53% 48.53% 49.63% 52.56%
Earnings before Interest and Taxes (EBIT)
-18 -23 -31 -28 -15 -26 -24 -23 -15 -13 -16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
7.20 1.80 -2.60 3.40 17 12 17 20 27 21 16
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.66 3.10 2.38 2.12 2.25 1.78 1.79 1.92 2.07 1.96 5.03
Price to Tangible Book Value (P/TBV)
33.50 22.99 9.62 8.02 9.85 11.31 9.59 10.39 10.38 9.61 0.00
Price to Revenue (P/Rev)
4.35 4.08 3.63 3.17 3.06 2.38 2.32 2.43 2.50 2.27 3.91
Price to Earnings (P/E)
0.00 0.00 27.74 19.65 18.32 14.96 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 3.61% 5.09% 5.46% 6.69% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
3.42 2.88 2.29 2.03 2.07 1.60 1.62 1.73 1.83 1.73 3.83
Enterprise Value to Revenue (EV/Rev)
4.47 4.24 3.73 3.29 3.30 2.78 2.68 2.76 2.85 2.64 4.23
Enterprise Value to EBITDA (EV/EBITDA)
58.42 320.93 471.01 205.40 131.63 97.76 58.76 47.09 43.62 36.78 61.31
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
15.99 24.06 26.34 40.77 53.11 19.25 20.28 16.70 17.12 22.25 33.94
Enterprise Value to Free Cash Flow (EV/FCFF)
130.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.49
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.80 0.79 0.66 0.66 0.61 0.60 0.60 0.60 0.60 0.62 0.90
Long-Term Debt to Equity
0.79 0.78 0.66 0.66 0.61 0.60 0.60 0.60 0.60 0.62 0.43
Financial Leverage
0.10 0.07 0.05 0.10 0.14 0.21 0.17 0.17 0.23 0.31 0.33
Leverage Ratio
2.10 2.06 2.01 2.00 1.96 1.94 1.89 1.87 1.84 1.85 2.02
Compound Leverage Factor
2.82 2.06 2.37 2.41 3.36 2.02 2.02 1.83 2.14 2.21 3.01
Debt to Total Capital
44.41% 44.08% 39.88% 39.85% 37.69% 37.56% 37.44% 37.36% 37.66% 38.11% 47.39%
Short-Term Debt to Total Capital
0.27% 0.27% 0.25% 0.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 24.88%
Long-Term Debt to Total Capital
44.13% 43.81% 39.63% 39.60% 37.69% 37.56% 37.44% 37.36% 37.66% 38.11% 22.51%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
55.59% 55.92% 60.12% 60.16% 62.31% 62.44% 62.56% 62.64% 62.34% 61.89% 52.61%
Debt to EBITDA
12.39 78.52 128.01 61.90 32.91 28.28 17.04 12.83 11.18 9.95 10.12
Net Debt to EBITDA
1.60 11.70 12.63 7.54 9.34 13.99 7.80 5.77 5.33 5.14 4.77
Long-Term Debt to EBITDA
12.31 78.04 127.22 61.52 32.91 28.28 17.04 12.83 11.18 9.95 4.81
Debt to NOPAT
-24.47 -12.82 -13.68 -14.65 -12.91 -11.80 -12.67 -13.42 -13.45 -15.89 -17.83
Net Debt to NOPAT
-3.16 -1.91 -1.35 -1.78 -3.67 -5.84 -5.80 -6.03 -6.41 -8.21 -8.41
Long-Term Debt to NOPAT
-24.32 -12.74 -13.60 -14.56 -12.91 -11.80 -12.67 -13.42 -13.45 -15.89 -8.47
Altman Z-Score
3.35 3.10 2.83 2.72 2.98 2.52 2.51 2.63 2.75 2.70 3.45
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.53 5.32 4.19 4.49 3.88 2.88 2.78 2.86 2.93 3.04 1.12
Quick Ratio
3.85 4.62 3.68 3.90 3.23 2.24 2.15 2.21 2.16 2.28 0.86
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
63 -27 -297 -250 -277 -438 -231 -207 -180 -0.09 442
Operating Cash Flow to CapEx
376.92% -152.22% 844.16% -125.27% 485.11% 1,359.26% 866.67% 247.54% 256.90% 183.19% 549.59%
Free Cash Flow to Firm to Interest Expense
10.26 0.00 0.00 -42.37 -25.63 -397.92 -8.12 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
6.43 0.00 0.00 -1.93 2.11 66.73 2.01 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
4.72 0.00 0.00 -3.47 1.68 61.82 1.78 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.39 0.36 0.35 0.37 0.40 0.41 0.40 0.41 0.45 0.46 0.51
Accounts Receivable Turnover
5.39 5.18 6.26 7.93 7.39 7.51 7.88 8.69 8.20 7.96 8.14
Inventory Turnover
3.56 3.91 4.14 4.18 4.44 4.59 4.69 4.76 4.69 4.49 4.47
Fixed Asset Turnover
15.03 13.14 13.52 13.33 13.80 14.33 14.56 14.14 14.45 15.27 15.06
Accounts Payable Turnover
6.51 7.77 7.80 7.14 6.50 7.04 6.39 7.11 7.24 7.88 7.31
Days Sales Outstanding (DSO)
67.71 70.51 58.27 46.03 49.37 48.61 46.33 42.01 44.52 45.86 44.86
Days Inventory Outstanding (DIO)
102.46 93.41 88.23 87.22 82.24 79.56 77.90 76.71 77.82 81.24 81.60
Days Payable Outstanding (DPO)
56.10 46.97 46.82 51.09 56.15 51.83 57.16 51.33 50.39 46.31 49.94
Cash Conversion Cycle (CCC)
114.06 116.95 99.68 82.16 75.46 76.34 67.07 67.38 71.95 80.79 76.52
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,346 1,381 1,563 1,586 1,613 1,800 1,777 1,776 1,782 1,791 1,324
Invested Capital Turnover
0.74 0.68 0.67 0.67 0.68 0.65 0.64 0.66 0.67 0.65 0.77
Increase / (Decrease) in Invested Capital
-75 14 276 230 266 419 214 191 170 -8.80 -453
Enterprise Value (EV)
4,598 3,980 3,580 3,225 3,330 2,884 2,879 3,066 3,263 3,093 5,070
Market Capitalization
4,472 3,834 3,484 3,106 3,094 2,471 2,497 2,690 2,864 2,661 4,675
Book Value per Share
$31.13 $31.43 $37.14 $37.07 $34.35 $35.39 $36.19 $36.23 $35.49 $35.08 $24.06
Tangible Book Value per Share
$3.41 $4.24 $9.17 $9.78 $7.84 $5.57 $6.76 $6.69 $7.08 $7.15 ($3.38)
Total Capital
2,195 2,209 2,440 2,439 2,209 2,221 2,230 2,236 2,220 2,195 1,767
Total Debt
975 974 973 972 833 834 835 835 836 837 837
Total Long-Term Debt
969 968 967 966 833 834 835 835 836 837 398
Net Debt
126 145 96 118 236 413 382 376 399 432 395
Capital Expenditures (CapEx)
10 9.00 7.70 9.10 4.70 5.40 6.60 12 12 12 12
Debt-free, Cash-free Net Working Capital (DFCFNWC)
51 89 14 38 65 44 29 27 70 103 83
Debt-free Net Working Capital (DFNWC)
900 918 891 892 661 465 481 487 508 507 525
Net Working Capital (NWC)
894 912 885 886 661 465 481 487 508 507 86
Net Nonoperating Expense (NNE)
-3.53 5.92 -230 3.22 -12 3.39 -12 4.36 4.23 -0.89 436
Net Nonoperating Obligations (NNO)
126 145 96 118 236 413 382 376 399 432 395
Total Depreciation and Amortization (D&A)
25 25 29 32 32 38 41 43 42 34 32
Debt-free, Cash-free Net Working Capital to Revenue
5.00% 9.48% 1.48% 3.92% 6.40% 4.21% 2.65% 2.44% 6.13% 8.77% 6.92%
Debt-free Net Working Capital to Revenue
87.51% 97.69% 92.88% 91.08% 65.44% 44.77% 44.77% 43.91% 44.36% 43.28% 43.88%
Net Working Capital to Revenue
86.92% 97.05% 92.26% 90.46% 65.44% 44.77% 44.77% 43.91% 44.36% 43.28% 7.16%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.23) ($0.46) $5.32 ($0.58) $0.05 ($0.56) ($0.13) ($0.53) ($0.38) ($0.21) ($11.50)
Adjusted Weighted Average Basic Shares Outstanding
39.20M 39.30M 39.20M 39.80M 39.70M 39M 39.30M 38.80M 38.90M 38.80M 38.90M
Adjusted Diluted Earnings per Share
($0.23) ($0.46) $5.28 ($0.58) $0.05 ($0.56) ($0.13) ($0.53) ($0.38) ($0.21) ($11.50)
Adjusted Weighted Average Diluted Shares Outstanding
39.20M 39.30M 39.70M 39.80M 39.80M 39M 39.30M 38.80M 38.90M 38.80M 38.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
39.30M 39.50M 39.58M 40.06M 39.19M 38.55M 38.66M 38.99M 38.73M 38.64M 39.11M
Normalized Net Operating Profit after Tax (NOPAT)
-12 -12 -21 -9.94 -10 -8.40 -16 -14 -11 -8.89 -11
Normalized NOPAT Margin
-4.90% -5.19% -8.40% -3.86% -3.77% -3.15% -5.64% -4.95% -3.47% -3.02% -3.50%
Pre Tax Income Margin
-10.13% -9.82% -14.83% -13.31% -9.73% -10.28% -9.12% -7.76% -5.79% -5.17% -7.79%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-2.93 0.00 0.00 -4.81 -1.41 -23.91 -0.85 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
-2.05 0.00 0.00 -3.37 -0.99 -16.74 -0.59 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-4.64 0.00 0.00 -6.36 -1.84 -28.82 -1.08 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-3.76 0.00 0.00 -4.91 -1.42 -21.65 -0.83 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-140.46% -78.61% 0.00% 0.00% 44.11% 67.98% -268.41% -299.12% -157.35% -204.99% -18.89%

Financials Breakdown Chart

Key Financial Trends

Synaptics’ recent results show improving revenue and gross margin, but the company remains unprofitable at the operating level. Quarterly revenue increased from $227.3 million in Q4 2023 to $308.0 million in Q4 2026, including growth from $282.8 million in Q4 2025. However, the company reported operating losses in each quarter of fiscal 2026, with a $16.1 million loss in Q4.

  • Revenue has recovered from the 2023 trough. Q4 revenue rose to $308.0 million in fiscal 2026 from $227.3 million in Q4 2023, while fiscal 2026 quarterly revenue remained near or above $292 million.
  • Gross margin improved sequentially. Q4 gross profit was $145.8 million, representing a margin of approximately 47.3%, up from about 44.9% in Q3 and 43.0% in Q4 2025.
  • Operating cash flow has remained positive. Synaptics generated $67.6 million of operating cash flow in Q4 2026 and positive operating cash flow in each fiscal 2026 quarter, despite reporting accounting losses.
  • Liquidity appears adequate in the near term. At the end of Q3 fiscal 2026, the company had $404.4 million of cash and $755.4 million of current assets against $248.2 million of current liabilities, implying a current ratio above 3.0.
  • Capital spending remains moderate. Q4 capital expenditures were $12.3 million, and quarterly spending has generally remained in the $11 million to $12 million range during fiscal 2026.
  • Cash generation is heavily dependent on working-capital movements. Q4 operating cash flow included a $432.7 million benefit from changes in operating assets and liabilities, which more than offset the $447.4 million net loss. This may not be sustainable without continued working-capital releases.
  • Share repurchases continue to support per-share value but consume cash. Synaptics repurchased $10.1 million of stock in Q4 2026 and roughly $92 million across fiscal 2026 through the first three quarters and Q4, while weighted-average shares declined modestly from approximately 39.3 million in Q4 2025 to 38.9 million in Q4 2026.
  • Operating profitability has not yet returned. Q4 operating expenses of $161.9 million exceeded gross profit by $16.1 million. Research and development spending alone was $97.8 million, or nearly one-third of revenue.
  • Q4 net loss was distorted by a major tax expense. Synaptics reported a $423.4 million income tax expense, turning a $24.0 million pretax loss into a $447.4 million net loss, or negative $11.50 per diluted share. Investors should distinguish this unusual charge from underlying operating performance, while recognizing that it materially reduced reported equity and earnings.
  • Debt and intangible-asset exposure remain substantial. Q3 fiscal 2026 long-term debt was $836.7 million versus $404.4 million of cash. Goodwill and intangible assets totaled approximately $1.08 billion, while deferred tax assets were $423.8 million, creating potential balance-sheet risk if earnings do not improve.

Overall, the financial trend is mixed. Revenue and gross margins are moving in the right direction, and positive operating cash flow provides some financial flexibility. Nevertheless, Synaptics has produced recurring operating losses since fiscal 2024, continues to carry meaningful debt, and relies on non-cash adjustments and working-capital benefits to convert reported losses into cash flow. A sustained return to operating profitability will be important for the stock’s longer-term outlook.

08/12/26 11:32 AM ETAI Generated. May Contain Errors.

Synaptics Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Synaptics' financial year ends in June. Their financial year 2026 ended on June 27, 2026.

Synaptics' net income appears to be on a downward trend, with a most recent value of -$490.80 million in 2026, falling from $72.20 million in 2016. The previous period was -$47.80 million in 2025. View Synaptics' forecast to see where analysts expect Synaptics to go next.

Synaptics' total operating income in 2026 was -$67.10 million, based on the following breakdown:
  • Total Gross Profit: $535.40 million
  • Total Operating Expenses: $602.50 million

Over the last 10 years, Synaptics' total revenue changed from $1.67 billion in 2016 to $1.20 billion in 2026, a change of -28.2%.

Synaptics' total liabilities were at $1.17 billion at the end of 2026, a 1.4% decrease from 2025, and a 97.0% increase since 2016.

In the past 10 years, Synaptics' cash and equivalents has ranged from $301 million in 2018 to $924.70 million in 2023, and is currently $442.50 million as of their latest financial filing in 2026.

Over the last 10 years, Synaptics' book value per share changed from 19.14 in 2016 to 24.06 in 2026, a change of 25.7%.



Financial statements for NASDAQ:SYNA last updated on 8/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners